Secretases as therapeutic targets for the treatment of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

http://www.wikidata.org/entity/Q34284352

about

PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin Immunization treatment approaches in Alzheimer's and prion diseases.Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease.Non-Catalytic Roles of Presenilin Throughout Evolution.Receptor- and non-receptor tyrosine kinases induce processing of the amyloid precursor protein: role of the low-density lipoprotein receptor-related protein.An inflammatory drug prospect.Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.Design of Peptide Hydroxamate-Based Photoreactive Activity-Based Probes of Zinc-Dependent Metalloproteases

P2860

Q24292718-ED091C7B-5437-4FFC-9BE8-0D935D16D8D6 Q24323262-93F6EB8D-2973-4D56-8557-907A66D54705 Q34778095-82E23E2D-E5A2-4780-82CA-920AD6864978 Q35031640-0926A943-7081-4749-BB53-A1281003A7C8 Q37053791-4B14E07C-F313-4DE5-B3CE-E1E6996101B5 Q40114409-DC613768-BFAD-4D58-92BE-989A74A8C0FB Q43793648-0570D154-C6DD-4AFB-8E8E-6936212F62EB Q48939073-0939CA97-4D2A-4EF3-8B68-5F2820F1BB62 Q57713000-6CC8804F-E7A1-445F-B82F-B2F83F43A262

P2860

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

http://www.wikidata.org/entity/Q34284352

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@ast

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@en

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@nl

type

label

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@ast

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@en

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@nl

prefLabel

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@ast

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@en

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@nl

P1433

Q34284352-42927AD4-694A-4515-A2BD-5D35F3A07C2E

P1476

Q34284352-51D5451C-B0CB-48ED-8CAA-5E9126958EC2

P2093

Q34284352-5C46ED04-ACC9-4D00-BF70-6AF088329095

Q34284352-89644C8C-B790-4D24-AB0F-7405AAB421E8

Q34284352-A45D9F1E-061E-426C-963D-A1D429462641

P2860

Q34284352-004CAC52-9C8F-4522-8737-4E5627EF9A98

Q34284352-0114D811-E5C2-4CB9-9C4A-26BA90E2A623

Q34284352-0143C7D2-E6BE-4BFB-A00E-23EE5B437223

Q34284352-02087036-B2F1-4433-B011-4DA628E441E2

Q34284352-036F629D-AA04-4336-945C-0CD0561C56FD

Q34284352-059E2870-8FDA-4543-8719-4B94519D7251

Q34284352-071C11CF-C5E6-48D7-B0A2-293C652B36A6

Q34284352-0805C19F-68A3-4E29-AA82-36747CBE0AB0

Q34284352-09209EB3-0090-4488-9C5F-F23DC9592D0B

Q34284352-0C7CECD5-98B6-403E-AFFA-D82FE76FADCA

P304

Q34284352-89A0FEA2-5B42-444C-8722-17674E935FA2

P31

Q34284352-89A22DFA-3A19-4484-94D4-A77F68AB22A5

P356

Q34284352-A827EB9F-7F12-45BA-AFF0-F732772D19E3

P433

Q34284352-BFEB18DE-EB3A-454E-B29C-C295A0379049

P478

Q34284352-7FD11AA0-4B6E-43DB-BAED-AB83581D78B0

P577

Q34284352-39B5D329-2CC4-4198-8464-E74E09F414A6

P698

Q34284352-B20FE7B8-D964-4EA2-B4E4-D0BD78FE656B

P921

Q34284352-52E4CC81-126D-45C2-9B2B-BE04E7792BB9

P356

13506120109007356

P1433

P1476

Secretases as therapeutic targets for the treatment of Alzheimer's disease.

@en

P2093

Annaert W

http://www.w3.org/2001/XMLSchema#string

De Strooper B

http://www.w3.org/2001/XMLSchema#string

Dominguez DI

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

Purification and cloning of amyloid precursor protein beta-secretase from human brain

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

Expression analysis of BACE2 in brain and peripheral tissues

Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state

Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing

Alzheimer's disease amyloid beta-clipping enzyme (APP secretase): identification, purification, and characterization of the enzyme

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

P304

124-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506120109007356

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11409035

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease